Obtaining and Applying Nanohybrid Palygorskite-Rifampicin in the pH-Responsive Release of the Tuberculostatic Drug
Despite having good efficacy in the treatment and prevention of tuberculosis, the administration of rifampicin (RIF) can cause serious side effects, resulting from the prolonged use of this substance. Thus, it is necessary to seek new systems for administering tuberculostatic drugs, to avoid unwante...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | Langmuir : the ACS journal of surfaces and colloids. - 1992. - 36(2020), 34 vom: 01. Sept., Seite 10251-10269
|
1. Verfasser: |
Damasceno Junior, Elmar
(VerfasserIn) |
Weitere Verfasser: |
Almeida, Janiele Mayara Ferreira de,
Silva, Isabel do Nascimento,
Assis, Mikaely Lizandra Moreira de,
Santos, Lamara Maciel Dos,
Dias, Elizete Faustino,
Silva, Francisco Emanuel da,
Fernandes, Nedja Suely,
Silva, Djalma Ribeiro da |
Format: | Online-Aufsatz
|
Sprache: | English |
Veröffentlicht: |
2020
|
Zugriff auf das übergeordnete Werk: | Langmuir : the ACS journal of surfaces and colloids
|
Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Magnesium Compounds
Pharmaceutical Preparations
Silicon Compounds
attapulgite
U6V729APAM
Rifampin
VJT6J7R4TR |